Novel cancer therapies for advanced cutaneous melanoma: The added value of radiomics in the decision making process–A systematic review-Reference-Cited by-同舟云学术

Novel cancer therapies for advanced cutaneous melanoma: The added value of radiomics in the decision making process–A systematic review

Published:2020-01-17 Issue:5 Volume:9 Page:1603-1612
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Guerrisi Antonino¹^ORCID,Loi Emiliano²,Ungania Sara²,Russillo Michelangelo³,Bruzzaniti Vicente²,Elia Fulvia¹,Desiderio Flora¹,Marconi Raffaella²,Solivetti Francesco Maria¹,Strigari Lidia²

Affiliation:

1. Radiology and Diagnostic Imaging Unit Department of Clinic and Dermatological Research San Gallicano Dermatological Institute IRCCS Rome Italy

2. Medical Physics and Expert Systems Laboratory Department of Research and Advanced Technologies Istituti Fisioterapici Ospitalieri ‐Regina Elena Institute IRCCS Rome Italy

3. Medical Oncology Unit 1 Department of Clinic and Cancer Research Regina Elena InstituteIRCCS Rome Italy

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2709

Reference56 articles.

1. Epidemiology of Melanoma

2. Clinical and prognostic factors for melanoma of the skin using SEER registries: Collaborative stage data collection system, version 1 and version 2

3. Survival rates of patients with metastatic malignant melanoma;Sandru A;J Med Life,2014

4. Cell death-based treatments of melanoma:conventional treatments and new therapeutic strategies

5. Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine learning in the prediction of immunotherapy response and prognosis of melanoma: a systematic review and meta-analysis;Frontiers in Immunology;2024-05-21

2. Pre-treatment 18F-FDG-PET/CT parameters as biomarkers for progression free survival, best overall response and overall survival in metastatic melanoma patients undergoing first-line immunotherapy;PLOS ONE;2024-01-05

3. Can Whole-Body Baseline CT Radiomics Add Information to the Prediction of Best Response, Progression-Free Survival, and Overall Survival of Stage IV Melanoma Patients Receiving First-Line Targeted Therapy: A Retrospective Register Study;Diagnostics;2023-10-14

4. A Decision Support System for the Identification of Metastases of Metastatic Melanoma Using Whole-Body FDG PET/CT Images;IEEE Journal of Biomedical and Health Informatics;2023-03

5. Imaging to predict checkpoint inhibitor outcomes in cancer. A systematic review;European Journal of Cancer;2022-11